17 Dec 2019 09:00
GlaxoSmithKline plc
Blocklisting Application
Application has been made to the Financial Conduct Authority and the London Stock Exchange plc for a total of 370,000 Ordinary Shares of 25p each ('Shares') to be admitted to the Official List.
The Shares are being reserved under an existing blocklisting and will be issued under the GlaxoSmithKline plc 2009 Deferred Annual Bonus Plan.
When issued, the Shares will rank pari passu with the existing Ordinary Shares of 25p each.
Admission is expected to be effective on 18 December 2019.
Victoria Whyte
Company Secretary
17 December 2019